RAUSERPIN Drug Patent Profile
✉ Email this page to a colleague
When do Rauserpin patents expire, and what generic alternatives are available?
Rauserpin is a drug marketed by Ferndale Labs and is included in one NDA.
The generic ingredient in RAUSERPIN is rauwolfia serpentina root. There are eight drug master file entries for this compound. Additional details are available on the rauwolfia serpentina root profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RAUSERPIN?
- What are the global sales for RAUSERPIN?
- What is Average Wholesale Price for RAUSERPIN?
Summary for RAUSERPIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 38 |
| Patent Applications: | 181 |
| DailyMed Link: | RAUSERPIN at DailyMed |
US Patents and Regulatory Information for RAUSERPIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferndale Labs | RAUSERPIN | rauwolfia serpentina root | TABLET;ORAL | 009926-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ferndale Labs | RAUSERPIN | rauwolfia serpentina root | TABLET;ORAL | 009926-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
